We also investigate the relationship between SLC34A1-related genes and the prognosis of ccRCC, as well as gene mutation and DNA methylation, providing new target genes for future transformation and clinical treatment. This evidence concerns the gene SLC34A1 and nonpapillary renal cell carcinoma.